South Korean President Orders Review of Abortion Medication Use Before Legal Changes
Translated from Korean, summarized and contextualized by DistantNews.
At a glance
- South Korean President Lee Jae-myung has ordered a review of allowing the use of medication for induced abortions, even before legal revisions.
- This directive challenges the Ministry of Food and Drug Safety's previous stance of delaying approval pending legislative changes.
- The move signals a potential shift in policy regarding access to abortion-inducing drugs in South Korea.
South Korean President Lee Jae-myung has called for a review into the practical use of medication for induced abortions, suggesting it could be permitted under medical discretion even before the law is formally amended. The President's directive signals a potential shift in the government's approach to reproductive health.
Previously, the Ministry of Food and Drug Safety had deferred decisions on approving such medications, citing the need for revisions to the Mother and Child Health Act. Lee's intervention directly questions this cautious approach, emphasizing the potential risks faced by citizens when access to safe medical options is delayed.
During a State Council meeting, President Lee stated, "The government may evade responsibility by leaving it outside the law, but the people fall into danger." His remarks highlight a tension between legal frameworks and the immediate health needs of individuals, suggesting a move towards prioritizing practical solutions while legislative processes catch up.
The government may evade responsibility by leaving it outside the law, but the people fall into danger.
Originally published by Chosun Ilbo in Korean. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.